A Gel-Free Quantitative Proteomics Analysis of Factors Released From Hypoxic-Conditioned Placentae

Characterizing the protein factors released from placentae during pathogenesis remains a key objective toward understanding preeclampsia and related pregnancy disorders. Gel-free proteomics technologies applied to placental explant-conditioned media offers the potential of identifying these factors. Relative quantification mass spectrometry using isobaric tagging for relative and absolute quantification (iTRAQ) labeling was employed to compare the ‘‘secretome’’ between healthy term placental tissue cultured under both normoxic and hypoxic oxygen tensions. Of the 499 proteins identified, 45 were differentially expressed (P < .01 level), including interleukin 8 (IL-8) which was significantly upregulated under hypoxia. Global protein level changes are suggestive of decreased extracellular matrix remodeling under the same conditions. A significant enrichment of soluble liberated placental factors is achieved using this model system. Identifying these changes resulting from hypoxic conditioning is hypothesis generating and may provide new mechanistic insights into preeclampsia.

[1]  W. N. Chen,et al.  Comparative Proteomics Analysis of Vascular Smooth Muscle Cells Incubated with S- and R-Enantiomers of Atenolol Using iTRAQ-coupled Two-dimensional LC-MS/MS*S , 2008, Molecular & Cellular Proteomics.

[2]  Crispin J. Miller,et al.  Eight-channel iTRAQ Enables Comparison of the Activity of Six Leukemogenic Tyrosine Kinases*S , 2008, Molecular & Cellular Proteomics.

[3]  T. Takizawa,et al.  Proteomics of the human placenta: promises and realities. , 2008, Placenta.

[4]  I. Crocker,et al.  Oxygen and the liberation of placental factors responsible for vascular compromise , 2008, Laboratory Investigation.

[5]  T. Thannhauser,et al.  A comparison of nLC-ESI-MS/MS and nLC-MALDI-MS/MS for GeLC-based protein identification and iTRAQ-based shotgun quantitative proteomics. , 2007, Journal of biomolecular techniques : JBT.

[6]  Sean L Seymour,et al.  The Paragon Algorithm, a Next Generation Search Engine That Uses Sequence Temperature Values and Feature Probabilities to Identify Peptides from Tandem Mass Spectra*S , 2007, Molecular & Cellular Proteomics.

[7]  Xi Li,et al.  Proteomic analysis of hypoxia-induced responses in the syncytialization of human placental cell line BeWo. , 2007, Placenta.

[8]  R. Beynon,et al.  Evidence for multiple circulating factors in preeclampsia. , 2007, American journal of obstetrics and gynecology.

[9]  J. Ernerudh,et al.  Cytokine mapping of sera from women with preeclampsia and normal pregnancies. , 2006, Journal of reproductive immunology.

[10]  H. Bitterman,et al.  Hypoxia reduces the output of matrix metalloproteinase‐9 (MMP‐9) in monocytes by inhibiting its secretion and elevating membranal association , 2006, Journal of leukocyte biology.

[11]  Gilbert S Omenn,et al.  Differential protein expression profiling by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/invasive phenotype. , 2006, Journal of proteome research.

[12]  J. Hamada,et al.  Hypoxia suppresses the production of matrix metalloproteinases and the migration of humanmonocyte‐derived dendritic cells , 2005, European journal of immunology.

[13]  D. Lewis,et al.  Hypoxia Promotes Interleukin-6 and -8 but Reduces Interleukin-10 Production by Placental Trophoblast Cells From Preeclamptic Pregnancies , 2005, The Journal of the Society for Gynecologic Investigation: JSGI.

[14]  G. Mires,et al.  In Preeclampsia, the Circulating Factors Capable of Altering In Vitro Endothelial Function Precede Clinical Disease , 2005, Hypertension.

[15]  Yuh‐Cheng Yang,et al.  Hypoxia and Transforming Growth Factor-β1 Act Independently to Increase Extracellular Matrix Production by Placental Fibroblasts , 2005 .

[16]  Hiroaki Kitano,et al.  The PANTHER database of protein families, subfamilies, functions and pathways , 2004, Nucleic Acids Res..

[17]  R. Ness,et al.  Evidence for the functional activity of hypoxia-inducible transcription factors overexpressed in preeclamptic placentae. , 2004, Placenta.

[18]  M. Campbell,et al.  PANTHER: a library of protein families and subfamilies indexed by function. , 2003, Genome research.

[19]  J. Aplin,et al.  Placental extracellular matrix: gene expression, deposition by placental fibroblasts and the effect of oxygen. , 2003, Placenta.

[20]  I. Johnson,et al.  The preliminary characterization of a vasoactive circulating factor(s) in preeclampsia. , 2001, American journal of obstetrics and gynecology.

[21]  A. Burlingame,et al.  Functional proteomics: examining the effects of hypoxia on the cytotrophoblast protein repertoire. , 2001, Biochemistry.

[22]  S. Thornton,et al.  The effects of placental extracts from normotensive and preeclamptic women on vasoconstriction and oxidative metabolism. , 2000, American journal of obstetrics and gynecology.

[23]  A. Warren,et al.  Plasma from women with pre‐eclampsia induces an in vitro alteration in the endothelium‐dependent behaviour of myometrial resistance arteries , 2000, BJOG : an international journal of obstetrics and gynaecology.

[24]  S. Bewley,et al.  Pre‐eclamptic toxaemia: the role of uterine artery Doppler , 1998, British journal of obstetrics and gynaecology.

[25]  T. Musci,et al.  Preeclampsia: an endothelial cell disorder. , 1989, American journal of obstetrics and gynecology.

[26]  I. Crocker,et al.  An image analysis technique for the investigation of human placental morphology in pregnancies complicated by pre-eclampsia and intrauterine growth restriction , 2004 .

[27]  J. Granger,et al.  Decreased endothelium-dependent vascular relaxation during reduction of uterine perfusion pressure in pregnant rat. , 2000, Hypertension.